Search

everythinglearnresearchcommunity

for

Search:↓

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

17β-Estradiol slows wound healing in male mice through estrogen receptor-α.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Adult skin cell-based early-stage skin substitutes improve wound healing and hair growth in mice.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Triboelectric nanogenerators can use body movement to power therapeutic treatments, potentially transforming personalized healthcare.

DHEA therapy improves pubic hair growth and psychological well-being in girls with central adrenal insufficiency.

Polymers increased skin permeation and stability of steroid hormones in liposomal formulations.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Applying heat with certain chemicals can greatly improve how well isotretinoin gets into the skin through hair follicles.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

Microagulhamento e intradermoterapia juntos melhoram o crescimento capilar em mulheres menopausadas.